(AOF) – Intuitive Surgical is expected to rise in pre-market trading on Wall Street after the US Food and Drug Administration (FDA) granted 510(k) clearance to da Vinci 5, its robotics platform latest generation surgical procedure which will be able to be marketed in the United States. “Intuitive is committed to making meaningful improvements to surgery that enable better patient outcomes, improve the patient and care team experience, and ultimately reduce the total cost of care,” reacts medtech.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
